Low-dose Hormone Therapy for Relief of Vasomotor Symptoms
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the lowest effective dose of the study drug for the
relief of moderate to severe vasomotor symptoms in postmenopausal women for 12 weeks.